Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

AIDS. 2000 Nov 10;14(16):2615-7. doi: 10.1097/00002030-200011100-00029.

Authors

E Martínez¹, M A García-Viejo, M A Marcos, J B Pérez-Cuevas, J L Blanco, J Mallolas, J M Miró, J M Gatell

Affiliation

¹ Infectious Diseases Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic Universitari, Barcelona, Spain.

PMID: 11101078
DOI: 10.1097/00002030-200011100-00029

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

AIDS-Related Opportunistic Infections / microbiology
AIDS-Related Opportunistic Infections / prevention & control
Adult
Antifungal Agents / therapeutic use*
Antiretroviral Therapy, Highly Active / statistics & numerical data*
CD4 Lymphocyte Count
Cerebrospinal Fluid / microbiology
Chemoprevention
Female
Fluconazole / therapeutic use*
HIV Infections / drug therapy*
HIV Infections / immunology*
Humans
Male
Meningitis, Cryptococcal / microbiology
Meningitis, Cryptococcal / prevention & control*
Middle Aged

Substances

Antifungal Agents
Fluconazole